Peter Doshi, editor at The BMJ, recently published the following opinion piece. To view the article, click on the title below.
Does the FDA think these data justify the first full approval of a covid-19 vaccine?
August 23, 2021
The FDA should demand adequate, controlled studies with long term follow up, and make data publicly available, before granting full approval to covid-19 vaccines, says Peter Doshi
